default author photo

Dirk Schadendorf

University of Duisburg-Essen - University Hospital Essen

SCHOLARLY PAPERS

6

DOWNLOADS

253

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Supporting Dermatologists with Explainable Ai: Exploring the Effects of Consistency and Explanation Approaches

Number of pages: 36 Posted: 11 Dec 2024
Alisa Küper, Georg Lodde, Elisabeth Livingstone, Dirk Schadendorf and Nicole Krämer
affiliation not provided to SSRN, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen and affiliation not provided to SSRN
Downloads 64 (942,565)

Abstract:

Loading...

AI reliance, explainable AI, Clinical Decision Support Systems, medical decision-making

2.

Neonatal Melanoma with Lymph Node Metastasis

Number of pages: 7 Posted: 22 Oct 2024
Marko Jevric, Igor Salatic, Dimitrije Brasanac, Klaus Georg Griewank, Axel Hauschild, Dirk Schadendorf, Miona Stojanovic Milosavljevic, Jelena Filipovic, Marija Dencic-Fekete, Vernon K. Sondak, Milan Zegarac and Lidija Kandolf
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Military Medical Academy of Belgrade
Downloads 48 (1,133,231)

Abstract:

Loading...

neonatal melanoma surgery treatment

3.

Characterization and Outcome of RAC1 Mutated Melanoma

Number of pages: 24 Posted: 29 Nov 2022
Georg Lodde, Philipp Jansen, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Antje Sucker, Jan-Malte Placke, Anne Zaremba, Lea Jessica Albrecht, Bernd Kowall, Wolfgang Galetzka, Jürgen Becker, Alpaslan Tasdogan, Lisa Zimmer, Elisabeth Livingstone, Eva Hadaschik, Dirk Schadendorf, Selma Ugurel and Klaus Georg Griewank
University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, Helios Klinikum Erfurt, University of Lubeck, Heidelberg University - Department of Dermatology, Saarland University - Medical School, Harzklinikum Dorothea Christiane Erxleben, University of Witten/Herdecke - Witten/Herdecke University Hospital, Elbe Kliniken Buxtehude, University Hospital Mühlenkreiskliniken Minden, Dresden University of Technology, Ludwigshafen Medical Center, Schleswig-Holstein University, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen and University of Duisburg-Essen - University Hospital Essen
Downloads 42 (1,157,785)

Abstract:

Loading...

Melanoma, RAC1 mutation, mutational analysis, systemic treatment, immune checkpoint inhi-bition, targeted therapy

4.

PTHrP-Induced Hypercalcemic Psychosyndrome Under Immune Checkpoint Blockade in Penile Squamous Cell Carcinoma – a Case Report

Number of pages: 13 Posted: 02 Feb 2024
Lea Jessica Albrecht, Viktor Grünwald, Jürgen Becker, Ralf Gutzmer, Livia Asan, Ellen Uslar, Alexandra Eilers, Anne-Christine Müseler, Alexander Roesch, Dirk Schadendorf, Lisa Zimmer and Elisabeth Livingstone
University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University Hospital Mühlenkreiskliniken Minden, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen and University of Duisburg-Essen - University Hospital Essen
Downloads 41 (1,209,354)

Abstract:

Loading...

immune checkpoint inhibition, hypercalcemia of malignancy, penile squamous cell carcinoma, hypercalcemic psychosyndrome, immune-mediated hypercalcemia

5.

Enhanced Overall and Progression-Free Survival in Advanced Melanoma Patients undergoing Targeted Therapy alongside Antithrombotic Treatment – Insights from a Multicenter Study involving 1,296 Patients from the Prospective Skin Cancer Registry ADOReg

Number of pages: 26 Posted: 31 Oct 2025
Noah Zimmermann, Julian Kött, Tim Zell, Ali Zeinal Abedini, Chiara L. Blomen, Stella Belz, Benjamin Deitert, Isabel Heidrich, Glenn Geidel, Alessandra Rünger, Daniel J. Smit, Michael Weichenthal, Selma Ugurel, Ulrike Leiter, Carola Berking, Ralf Gutzmer, Dirk Schadendorf, Imke von Wasielewski, Peter Mohr, Friedegund Meier, Rudolf Herbst, Jochen Utikal, Patrick Terheyden, Sebastian Haferkamp, Claudia Pföhler, Martin Kaatz, Fabian Ziller, Jens Ulrich, Frank Meiss, Alexander T. Bauer, Stefan W. Schneider and Christoffer Gebhardt
University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, affiliation not provided to SSRN, University of Hamburg - University Medical Center Hamburg-Eppendorf, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Kiel, affiliation not provided to SSRN, University of Tübingen, University Hospital Erlangen, University Hospital Mühlenkreiskliniken Minden, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN, Elbe Kliniken Buxtehude, affiliation not provided to SSRN, Helios Klinikum Erfurt, Heidelberg University - Department of Dermatology, affiliation not provided to SSRN, Universitat Regensburg, Saarland University - Medical School, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Freiburg, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf and University Medical Center Hamburg- Eppendorf
Downloads 32 (1,304,549)

Abstract:

Loading...

melanoma, targeted therapy, BRAF and MEK inhibitors, Anticoagulation, Direct oral anticoagulants (DOACs), Factor Xa inhibitors, Progression-free survival (PFS), Overall survival (OS), Platelet aggregation inhibition, Venous thromboembolism (VTE), Immunothrombosis

6.

Sex-Specific Survival in Advanced Metastatic Melanoma – a Decog Study on 2032 Patients of the Multicenter Prospective Skin Cancer Registry Adoreg

Number of pages: 24 Posted: 06 Jun 2025
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, Michael Weichenthal, Peter Mohr, Friedegund Meier, Imke von Wasielewski, Ralf Gutzmer, Jochen Utikal, Patrick Terheyden, Rudolf Herbst, Sebastian Haferkamp, Claudia Pföhler, Ulrike Leiter, Andrea Forschner, Alexander Kreuter, Christoffer Gebhardt, Stine Lutze, Carsten Weishaupt, Stephan Grabbe, Dirk Debus, Jessica Cecile Hassel, Julia Welzel, Lucie Heinzerling, Carola Berking, Carmen Loquai, Thilo Gambichler, Mirjana Ziemer, Jürgen Becker, Alpaslan Tasdogan, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Alexander Roesch, Anke Hinney and Selma Ugurel
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Schleswig-Holstein University, Elbe Kliniken Buxtehude, Dresden University of Technology, affiliation not provided to SSRN, University Hospital Mühlenkreiskliniken Minden, Heidelberg University - Department of Dermatology, University of Lubeck, Helios Klinikum Erfurt, University Hospital Regensburg (UKR), Saarland University - Medical School, University of Tübingen, University of Tübingen, University of Witten/Herdecke - Witten/Herdecke University Hospital, University Medical Center Hamburg- Eppendorf, affiliation not provided to SSRN, Universitätsklinikum Münster, affiliation not provided to SSRN, Paracelsus Medical University Nuremberg - General Hospital Nuremberg, Heidelberg University - University Hospital Heidelberg, University Hospital Augsburg, Ludwig Maximilian University of Munich (LMU), University Hospital Erlangen, affiliation not provided to SSRN, affiliation not provided to SSRN, Leipzig University, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 26 (1,385,945)

Abstract:

Loading...

Melanoma, sex, Targeted therapy, immune checkpoint inhibition therapy, Survival